MedPage Today on MSN
GLP-1 drugs may benefit cancer patients with brain lesions
Retrospective study finds link between blockbuster drugs and longer survival ...
A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.
Add Yahoo as a preferred source to see more of our stories on Google. Over two million people worldwide are diagnosed with colorectal cancer every year, with up to 40 per cent of these patients facing ...
Drugs are scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There's even a "uni-drug" that may fight many forms of the disease.
Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or ...
Hydralazine has been used to treat high blood pressure for many decades, even though it's never been exactly clear how it works. Now a new study answers some key questions about the medication – and ...
Good news for a grave concern. Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a new standard of care and improved survival ...
A cohort study found that commonly prescribed medications did not seem to affect treatment outcomes in veterans with stage IV non-small cell lung cancer (NSCLC) who received immune checkpoint ...
Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down. Researchers are now unraveling how these medications affect immune ...
A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results